Digital repository of Slovenian research organisations

Search the repository
A+ | A- | Help | SLO | ENG

Query: search in
search in
search in
search in

Options:
  Reset


Query: "author" (Martina Reberšek) .

1 - 10 / 87
First pagePrevious page123456789Next pageLast page
1.
Gut microbiome and its role in colorectal cancer
Martina Reberšek, 2021, review article

Abstract: Colorectal cancer (CRC) is still one of the most common types of cancer in the world, and the gut microbiome plays an important role in its development. The microbiome is involved in the carcinogenesis, formation and progression of CRC as well as its response to different systemic therapies. The composition of bacterial strains and the influence of geography, race, sex, and diet on the composition of the microbiome serve as important information for screening, early detection and prediction of the treatment outcome of CRC. Microbiome modulation is one of the most prospective new strategies in medicine to improve the health of individuals. Therefore, future research and clinical trials on the gut microbiome in oncology as well as in the treatment of CRC patients are warranted to determine the efficacy of systemic treatments for CRC, minimize adverse effects and increase survival rates.
Published in DiRROS: 19.09.2022; Views: 92; Downloads: 43
.pdf Full text (1,72 MB)
This document has many files! More...

2.
3.
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients : a pilot study
Nežka Hribernik, Daniel T. Huff, Andrej Studen, Katarina Zevnik, Žan Klaneček, Hamid Emamekhoo, Katja Škalič, Robert Jeraj, Martina Reberšek, 2022, original scientific article

Abstract: Purpose: To develop quantitative molecular imaging biomarkers of immune-related adverse event (irAE) development in malignant melanoma (MM) patients receiving immune-checkpoint inhibitors (ICI) imaged with 18F-FDG PET/CT. Methods: 18F-FDG PET/CT images of 58 MM patients treated with anti-PD-1 or anti-CTLA-4 ICI were retrospectively analyzed for indication of irAE. Three target organs, most commonly affected by irAE, were considered: bowel, lung, and thyroid. Patient charts were reviewed to identify which patients experienced irAE, irAE grade, and time to irAE diagnosis. Target organs were segmented using a convolutional neural network (CNN), and novel quantitative imaging biomarkers - SUV percentiles (SUVX%) of 18F-FDG uptake within the target organs - were correlated with the clinical irAE status. Area under the receiver-operating characteristic curve (AUROC) was used to quantify irAE detection performance. Patients who did not experience irAE were used to establish normal ranges for target organ 18F-FDG uptake. Results: A total of 31% (18/58) patients experienced irAE in the three target organs: bowel (n=6), lung (n=5), and thyroid (n=9). Optimal percentiles for identifying irAE were bowel (SUV95%, AUROC=0.79), lung (SUV95%, AUROC=0.98), and thyroid (SUV75%, AUROC=0.88). Optimal cut-offs for irAE detection were bowel (SUV95%>2.7 g/mL), lung (SUV95%>1.7 g/mL), and thyroid (SUV75%>2.1 g/mL). Normal ranges (95% confidence interval) for the SUV percentiles in patients without irAE were bowel [1.74, 2.86 g/mL], lung [0.73, 1.46 g/mL], and thyroid [0.86, 1.99 g/mL]. Conclusions: Increased 18F-FDG uptake within irAE-affected organs provides predictive information about the development of irAE in MM patients receiving ICI and represents a potential quantitative imaging biomarker for irAE. Some irAE can be detected on 18F-FDG PET/CT well before clinical symptoms appear.
Keywords: melanoma, malignant melanoma, immune-checkpoint inhibitors, molecular imaging biomarkers
Published in DiRROS: 07.09.2022; Views: 108; Downloads: 42
.pdf Full text (9,65 MB)

4.
Izbrane teme iz internistične onkologije za zdravnike družinske medicine, Ljubljana, junij 2022
2022, proceedings of peer-reviewed scientific conference contributions (domestic conferences)

Keywords: internistična onkologija, družinska medicina, onkološko zdravljenje
Published in DiRROS: 30.08.2022; Views: 191; Downloads: 55
.pdf Full text (56,64 MB)

5.
Dnevnik zdravljenja z zdravilom regorafenib
Janja Ocvirk, Martina Reberšek, Neva Volk, Tanja Mesti, Marko Boc, Marija Ignjatović, Nežka Hribernik, 2022, dictionary, encyclopaedia, lexicon, manual, atlas, map

Keywords: kemoterapija, rak debelega črevesa in danke, gastrointestinalni tumorji
Published in DiRROS: 14.07.2022; Views: 332; Downloads: 70
.pdf Full text (2,48 MB)

6.
Adjuvantno sistemsko zdravljenje kožnega melanoma : Elektronski vir
Martina Reberšek, 2022, published scientific conference contribution

Keywords: melanom, rak kože, sistemsko zdravljenje
Published in DiRROS: 08.04.2022; Views: 250; Downloads: 88
.pdf Full text (543,87 KB)

7.
Melanom in nemelanomski kožni raki : uredniki zbornika Marko Boc ... [et al.]
2022, proceedings of professional or unreviewed scientific conference contributions

Keywords: rak kože, melanom, nemelanomski kožni raki
Published in DiRROS: 08.04.2022; Views: 301; Downloads: 167
.pdf Full text (39,15 MB)
This document has many files! More...

8.
Smernice za obravnavo bolnikov s skvamoznoceličnim karcinomom analnega kanala in kože perinealno (analnega roba)
2020, dictionary, encyclopaedia, lexicon, manual, atlas, map

Keywords: rak analnega kanala, rak analnega roba, bolniki, zdravljenje
Published in DiRROS: 18.03.2022; Views: 314; Downloads: 144
.pdf Full text (407,06 KB)
This document has many files! More...

9.
Priporočila za obravnavo bolnikov z rakom debelega črevesa in danke
2020, dictionary, encyclopaedia, lexicon, manual, atlas, map

Keywords: rak debelega črevesa, rak danke, bolniki, zdravljenje
Published in DiRROS: 18.03.2022; Views: 345; Downloads: 162
.pdf Full text (1,30 MB)
This document has many files! More...

10.
Search done in 0.6 sec.
Back to top